JNJ-4362
/ J&J
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
August 18, 2026
A Study of HLD-0117 in Patients With Metastatic Breast Cancer
(clinicaltrials.gov)
- P1 | N=170 | Recruiting | Sponsor: Janssen Research & Development, LLC | N=33 ➔ 170 | Trial completion date: Apr 2028 ➔ Oct 2029
Enrollment change • Trial completion date • Breast Cancer • Estrogen Receptor Positive Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor • ER • HER-2
April 14, 2026
A Study of HLD-0117 in Patients With Metastatic Breast Cancer
(clinicaltrials.gov)
- P1 | N=33 | Recruiting | Sponsor: Halda Therapeutics OpCo, Inc.
New P1 trial • Breast Cancer • Estrogen Receptor Positive Breast Cancer • Hormone Receptor Positive Breast Cancer • Oncology • Solid Tumor • ER • HER-2
1 to 2
Of
2
Go to page
1